City

Houston (2)

Boston (1)

Overall Status

Completed (2)

Withdrawn (1)

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Laser Tissue Welding, Inc. (1)

National Cancer Institute (NCI) (1)

Vanderbilt-Ingram Cancer Center (1)

Collaborator

National Cancer Institute (NCI) (2)

CHI St. Luke's Health, Texas (1)

Intervention

laboratory biomarker analysis (2)

pharmacological study (2)

capecitabine (1)

distal pancreatectomy sealing using ltw (1)

pazopanib hydrochloride (1)

temozolomide (1)

veliparib (1)

Study Documents

Intervention Type

drug (2)

other (2)

device (1)

Funder Type

Industry (1)

NIH (1)

Other (1)

Study Type

Interventional (3)

pancreatic glucagonoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Pancreatic Tumor, Benign, Pancreatic Tumors, Pancreatic Adenocarcinoma Trial in Houston (Distal Pancreatectomy Sealing Using

Completed

Pancreatic Tumor, Benign
+13 more

Distal Pancreatectomy Sealing Using LTW

Houston, Texas

Baylor CHI St. Luke's Medical Center

Apr 4, 2022

Gastrin-Producing Neuroendocrine Tumor, Lung Carcinoid Tumor, Metastatic Digestive System Neuroendocrine Tumor G1 Trial in

Completed

Has Results

Gastrin-Producing Neuroendocrine Tumor
+10 more

Laboratory Biomarker Analysis
+2 more

Boston, Massachusetts
+2 more

Mar 25, 2020

Functional Pancreatic Neuroendocrine Tumor, Malignant Somatostatinoma, Merkel Cell Carcinoma Trial (Capecitabine, Temozolomide,

Withdrawn

Functional Pancreatic Neuroendocrine Tumor
+28 more

Capecitabine
+4 more

(no location specified)

Sep 26, 2017